{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T19:46:48Z","timestamp":1765828008000,"version":"3.37.3"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"7-8","license":[{"start":{"date-parts":[[2021,1,27]],"date-time":"2021-01-27T00:00:00Z","timestamp":1611705600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,27]],"date-time":"2021-01-27T00:00:00Z","timestamp":1611705600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Wien Klin Wochenschr"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1007\/s00508-020-01807-6","type":"journal-article","created":{"date-parts":[[2021,1,27]],"date-time":"2021-01-27T11:03:18Z","timestamp":1611745398000},"page":"359-363","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Evaluating the longitudinal effectiveness of preventive measures against COVID-19 and seroprevalence of IgG antibodies to SARS-CoV-2 in cancer outpatients and healthcare workers"],"prefix":"10.1007","volume":"133","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5230-7173","authenticated-orcid":false,"given":"Dominic","family":"Fong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katja Olga","family":"San Nicol\u00f2","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monika","family":"Alber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manfred","family":"Mitterer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,1,27]]},"reference":[{"issue":"18","key":"1807_CR1","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","volume":"382","author":"WJ Guan","year":"2020","unstructured":"Guan\u00a0WJ, Ni\u00a0ZY, Hu\u00a0Y, et\u00a0al. Clinical characteristics of coronavirus disease 2019 in China. N\u00a0Engl J Med. 2020;382(18):1708\u201320.","journal-title":"N Engl J Med"},{"key":"1807_CR2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.5910","author":"DM Hartley","year":"2020","unstructured":"Hartley\u00a0DM, Perencevich\u00a0EN. Public health interventions for COVID-19: emerging evidence and implications for an evolving public health crisis. JAMA. 2020; https:\/\/doi.org\/10.1001\/jama.2020.5910.","journal-title":"JAMA"},{"issue":"3","key":"1807_CR3","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/S1470-2045(20)30096-6","volume":"21","author":"W Liang","year":"2020","unstructured":"Liang\u00a0W, Guan\u00a0W, Chen\u00a0R, et al. Cancer patients in SARS-CoV\u20112 infection: a nationwide analysis in China. Lancet Oncol. 2020;21(3):335\u20137.","journal-title":"Lancet Oncol"},{"issue":"6","key":"1807_CR4","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1158\/2159-8290.CD-20-0422","volume":"10","author":"M Dai","year":"2020","unstructured":"Dai\u00a0M, Liu\u00a0D, Liu\u00a0M, et al. Patients with cancer appear more vulnerable to SARS-coV-2: a multicenter study during the COVID-19 outbreak. Cancer Discov. 2020;10(6):783\u201391.","journal-title":"Cancer Discov"},{"key":"1807_CR5","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.4683","author":"G Onder","year":"2020","unstructured":"Onder\u00a0G, Rezza\u00a0G, Brusaferro\u00a0S. Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy. JAMA. 2020; https:\/\/doi.org\/10.1001\/jama.2020.4683.","journal-title":"JAMA"},{"issue":"7","key":"1807_CR6","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1001\/jamaoncol.2020.0980","volume":"6","author":"J Yu","year":"2020","unstructured":"Yu\u00a0J, Ouyang\u00a0W, Chua\u00a0MLK, Xie\u00a0C. SARS-CoV\u20112 transmission in patients with cancer at a\u00a0tertiary care hospital in Wuhan, China. JAMA Oncol. 2020;6(7):1108\u201310.","journal-title":"JAMA Oncol"},{"key":"1807_CR7","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.ejca.2020.03.028","volume":"132","author":"L Peng","year":"2020","unstructured":"Peng\u00a0L, Zagorac\u00a0S, Stebbing\u00a0J. Managing patients with cancer in the COVID-19 era. Eur J Cancer. 2020;132:5\u20137.","journal-title":"Eur J Cancer"},{"key":"1807_CR8","unstructured":"ESMO. Cancer patient management during COVID-19 pandemic. 2020. https:\/\/www.esmo.org\/guidelines\/cancer-patient-management-during-the-covid-19-pandemic. Accessed 27 July 2020."},{"key":"1807_CR9","unstructured":"NICE. COVID-19 rapid guideline: delivery of systemic anticancer treatments. 2020. https:\/\/www.nice.org.uk\/guidance\/ng161. Accessed 28 July 2020."},{"issue":"4","key":"1807_CR10","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/j.ijrobp.2020.04.016","volume":"107","author":"DJ Thomson","year":"2020","unstructured":"Thomson\u00a0DJ, Palma\u00a0D, Guckenberger\u00a0M, et al. Practice recommendations for risk-adapted head and neck cancer radiation therapy during the COVID-19 pandemic: an ASTRO-ESTRO consensus statement. Int J Radiat Oncol Biol Phys. 2020;107(4):618\u201327.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1807_CR11","unstructured":"World of Meters. Italy. 2020. https:\/\/www.worldometers.info\/coronavirus\/country\/italy\/. Accessed 28 July 2020."},{"key":"1807_CR12","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2020.4130","author":"FP Havers","year":"2020","unstructured":"Havers\u00a0FP, Reed\u00a0C, Lim\u00a0T, et al. Seroprevalence of antibodies to SARS-CoV\u20112 in 10 sites in the United States, march 23\u2013may 12. JAMA Intern Med. 2020; https:\/\/doi.org\/10.1001\/jamainternmed.2020.4130.","journal-title":"JAMA Intern Med"},{"key":"1807_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)31304-0","author":"S Stringhini","year":"2020","unstructured":"Stringhini\u00a0S, Wisniak\u00a0A, Piumatti\u00a0G, et al. Seroprevalence of anti-SARS-CoV\u20112 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a\u00a0population-based study. Lancet. 2020; https:\/\/doi.org\/10.1016\/S0140-6736(20)31304-0.","journal-title":"Lancet"},{"issue":"3","key":"1807_CR14","doi-asserted-by":"publisher","first-page":"e000810","DOI":"10.1136\/esmoopen-2020-000810","volume":"5","author":"D Fong","year":"2020","unstructured":"Fong\u00a0D, Rauch\u00a0S, Petter\u00a0C, et al. Infection rate and clinical management of cancer patients during the COVID-19 pandemic: experience from a\u00a0tertiary care hospital in northern Italy. ESMO Open. 2020;5(3):e810.","journal-title":"ESMO Open"},{"key":"1807_CR15","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00941-20","author":"A Bryan","year":"2020","unstructured":"Bryan\u00a0A, Pepper\u00a0G, Wener\u00a0MH, et al. Performance characteristics of the Abbott architect SARS-coV\u20112 IgG assay and seroprevalence in Boise, Idaho. J\u00a0Clin Microbiol. 2020; https:\/\/doi.org\/10.1128\/JCM.00941-20.","journal-title":"J Clin Microbiol"},{"issue":"11","key":"1807_CR16","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1001\/jama.2020.1585","volume":"323","author":"D Wang","year":"2020","unstructured":"Wang\u00a0D, Hu\u00a0B, Hu\u00a0C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020;323(11):1061\u20139.","journal-title":"JAMA"},{"key":"1807_CR17","unstructured":"Palmieri L, Andrianou X, Barbariol P, et al. Characteristics of SARS-CoV\u20112 patients dying in Italy. 2020. https:\/\/www.epicentro.iss.it\/en\/coronavirus\/sars-cov-2-analysis-of-deaths. Accessed 28 July 2020."},{"key":"1807_CR18","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.ejca.2020.04.034","volume":"133","author":"C Omarini","year":"2020","unstructured":"Omarini\u00a0C, Maur\u00a0M, Luppi\u00a0G, et\u00a0al. Cancer treatment during the coronavirus disease 2019 pandemic: do not postpone, do it! Eur J Cancer. 2020;133:29\u201332.","journal-title":"Eur J Cancer"},{"key":"1807_CR19","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.33148","author":"L Tao","year":"2020","unstructured":"Tao\u00a0L, Guang\u00a0Z, Huangheng\u00a0T, et al. Low prevalence of IgG antibodies to SARS-CoV\u20112 in cancer patients with COVID-19. Int J Cancer. 2020; https:\/\/doi.org\/10.1002\/ijc.33148.","journal-title":"Int J Cancer"},{"key":"1807_CR20","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-020-10046-8","author":"MS Woo","year":"2020","unstructured":"Woo\u00a0MS, Steins\u00a0D, H\u00e4u\u00dfler\u00a0V, et al. Control of SARS-CoV\u20112 infection in rituximab-treated neuroimmunological patients. J\u00a0Neurol. 2020; https:\/\/doi.org\/10.1007\/s00415-020-10046-8.","journal-title":"J Neurol"},{"key":"1807_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2020.102306","author":"V Meca-Lallana","year":"2020","unstructured":"Meca-Lallana\u00a0V, Aguirre\u00a0C, del R\u00edo\u00a0B, et al. COVID-19 in 7 multiple sclerosis patients in treatment with ANTI-CD20 therapies. Mult Scler Relat Disord. 2020; https:\/\/doi.org\/10.1016\/j.msard.2020.102306.","journal-title":"Mult Scler Relat Disord"},{"key":"1807_CR22","doi-asserted-by":"publisher","DOI":"10.1002\/art.41380","author":"B Fallet","year":"2020","unstructured":"Fallet\u00a0B, Kyburz\u00a0D, Walker\u00a0UA. Mild course of COVID-19 and spontaneous virus clearance in a\u00a0patient with depleted peripheral blood B cells due to rituximab treatment. Arthritis Rheumatol. 2020; https:\/\/doi.org\/10.1002\/art.41380.","journal-title":"Arthritis Rheumatol"},{"key":"1807_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-020-0949-6","author":"X Xu","year":"2020","unstructured":"Xu\u00a0X, Sun\u00a0J, Nie\u00a0S, et al. Seroprevalence of immunoglobulin M and G antibodies against SARS-CoV\u20112 in China. Nat Med. 2020; https:\/\/doi.org\/10.1038\/s41591-020-0949-6.","journal-title":"Nat Med"},{"issue":"12","key":"1807_CR24","doi-asserted-by":"publisher","first-page":"4417","DOI":"10.3390\/ijerph17124417","volume":"17","author":"E Lahner","year":"2020","unstructured":"Lahner\u00a0E, Dilaghi\u00a0E, Prestigiacomo\u00a0C, et al. Prevalence of Sars-Cov\u20112 infection in health workers (HWs) and diagnostic test performance: the experience of a\u00a0teaching hospital in central Italy. Int J Environ Res Public Health. 2020;17(12):4417.","journal-title":"Int J Environ Res Public Health"}],"container-title":["Wiener klinische Wochenschrift"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00508-020-01807-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00508-020-01807-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00508-020-01807-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,13]],"date-time":"2022-12-13T14:39:46Z","timestamp":1670942386000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00508-020-01807-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,27]]},"references-count":24,"journal-issue":{"issue":"7-8","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["1807"],"URL":"https:\/\/doi.org\/10.1007\/s00508-020-01807-6","relation":{},"ISSN":["0043-5325","1613-7671"],"issn-type":[{"type":"print","value":"0043-5325"},{"type":"electronic","value":"1613-7671"}],"subject":[],"published":{"date-parts":[[2021,1,27]]},"assertion":[{"value":"8 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical guidelines"}},{"value":"D.\u00a0Fong, K.O.\u00a0San Nicol\u00f2, M.\u00a0Alber, and M.\u00a0Mitterer declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants or on human tissue were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1975 Helsinki declaration and its later amendments or comparable ethical standards. The study was approved by the local ethics committee of the \u201cS\u00fcdtiroler Sanit\u00e4tsbetrieb\u201d (protocol number 35-2020). All subjects provided written informed consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standards"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}